Specifically, cancer is usually correlated with the acquisition of mutations that alter key cell signaling pathways, and mitogen-activated protein kinases (MAPKs) have been identified as a family of kinases that are highly implicated in different cancer processes [3]. This evidence concerns the gene WNK2 and cancer.